Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Neurocrine Biosciences, Inc. (NB3.F)

Compare
92.20
-3.86
(-4.02%)
At close: April 4 at 8:11:21 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,355,300
2,355,300
1,887,100
1,488,700
1,133,500
Cost of Revenue
34,000
34,000
39,700
23,200
14,300
Gross Profit
2,321,300
2,321,300
1,847,400
1,465,500
1,119,200
Operating Expense
1,738,300
1,738,300
1,452,600
1,216,500
911,400
Operating Income
583,000
583,000
394,800
249,000
207,800
Net Non Operating Interest Income Expense
91,000
91,000
52,800
4,100
-25,800
Other Income Expense
-188,000
-188,000
-115,500
-39,200
-80,600
Pretax Income
486,000
486,000
332,100
213,900
101,400
Tax Provision
144,700
144,700
82,400
59,400
11,800
Net Income Common Stockholders
341,300
341,300
249,700
154,500
89,600
Diluted NI Available to Com Stockholders
341,300
341,300
249,700
154,500
89,600
Basic EPS
3.88
3.40
2.56
1.61
0.95
Diluted EPS
3.75
3.29
2.47
1.56
0.92
Basic Average Shares
100,025
100,400
97,700
95,800
94,600
Diluted Average Shares
103,550
103,700
101,000
98,900
97,900
Total Operating Income as Reported
570,500
570,500
250,900
249,000
102,500
Total Expenses
1,772,300
1,772,300
1,492,300
1,239,700
925,700
Net Income from Continuing & Discontinued Operation
341,300
341,300
249,700
154,500
89,600
Normalized Income
473,325.51
473,325.51
336,542.37
182,814.17
160,820.51
Interest Income
91,000
91,000
52,800
4,100
--
Interest Expense
--
--
4,600
7,100
25,800
Net Interest Income
91,000
91,000
52,800
4,100
-25,800
EBIT
583,000
583,000
394,800
249,000
127,200
EBITDA
610,100
610,100
416,100
264,600
138,100
Reconciled Cost of Revenue
34,000
34,000
39,700
23,200
14,300
Reconciled Depreciation
27,100
27,100
21,300
15,600
10,900
Net Income from Continuing Operation Net Minority Interest
341,300
341,300
249,700
154,500
89,600
Total Unusual Items Excluding Goodwill
-188,000
-188,000
-115,500
-39,200
-80,600
Total Unusual Items
-188,000
-188,000
-115,500
-39,200
-80,600
Normalized EBITDA
798,100
798,100
531,600
303,800
218,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-55,974.49
-55,974.49
-28,657.63
-10,885.83
-9,379.49
12/31/2021 - 1/27/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade